Adiana Permanent Contraception Advantages
With Adiana Permanent Contraception, less is more
No incisions. No general anesthesia. No metal. No hormones. No pill burden. No other contraception system can offer all these benefits. Adiana Permanent Contraception delivers more with less without compromising. Adiana's 3-year efficacy rate of 98.4% is comparable to tubal ligation and higher than the 92% typical use rate for oral contraceptives. In the clinical trial, Adiana's bi-lateral placement rate was an impressive 95%.
With so many of innovative benefits, it's no wonder that 98% of patients reported their tolerance of the procedure as "well" to "excellent" in the clinical study.
Safe for your patients
- Promotes tissue ingrowth to occlude the fallopian tubes without chronic inflammation.
- Requires no incisions or general anesthesia, allowing most women to return to normal activities within a day.
- Utilizes a biocompatible, soft silicone, which has been safely used in implants for decades.
- No reported cases of long term side effects in the clinical trial.
- No reported cases of surgical removal or perforations in the clinical trial.
- No hormonal side effects.
- No risk of metal allergy.
Simple to use
- RF Generator or Procedure Guidance System(PGS) guides you through every step of the procedure for simplicity and predictable results.
- Clinical trial results showed that it takes less than 12 minutes on average to complete the procedure.
- Can be carried out in the comfort of an in-office environment.
- Atraumatic ball tip with lubricious coating facilitates cannulation.
Effective
- 98.4% 3 year efficacy rate is comparable to tubal ligation without the risk of surgery.
Nothing left in the uterus
- Implantable matrix is totally contained in the fallopian tube so there is nothing left in the uterus that might interfere with future gynecological procedures.
- Can use NovaSure® Endometrial Ablation after receiving HSG Confirmation of tubal occlusion without concerns of interference in the uterus.
Cost effective
- Quick, in-office procedure saves you time and money.
- Most insurance providers provide reimbursement under the code for hysteroscopic sterilization (58565). Please check with your insurance providers to confirm coverage.
Download the Coding and Reimbursement Guide
Proven safety, efficacy, and patient satisfaction
Adiana Clinical Study abstract
In a prospective randomized clinical trial, the Adiana procedure was performed on 645 women from ages 18 to 45. The results of the trial showed a strong safety profile, with very high device placement success, patient tolerance, comfort and satisfaction.
Efficacy
98.4% 3 year pregnancy prevention effectiveness rate shown in the clinical trial.
Safety1
No uterine or fallopian perforations.
No adverse device reactions - no allergies, no infections.
No removals requested or required.
Device Placement1
95% (611/645) successful bilateral placements.
Anesthesia1
No patients required general anesthesia.
Procedure Time1
11 minutes 54 second average procedure time.
Patient Comfort & Satisfaction1
99% of patients were "very satisfied" or "satisfied" with the procedure.
98% rated their tolerance of the procedure as "well" to "excellent".
98% of patients returned to normal activities in 1 or 2 days.